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Abstract
Major scholars in the field, based on a 3-day consensus, created an in-depth review of current 
knowledge on the role of diet in CVD, the changing global food system and global dietary 
patterns, and potential policy solutions. Evidence from different countries, age/race/ethnicity/
socioeconomic groups suggest the health effects studies of foods, macronutrients, and dietary 
patterns on CVD appear to be far more consistent though regional knowledge gaps are 
highlighted. There are large gaps in knowledge about the association of macronutrients to CVD in 
low- and middle-income countries (LMIC), particularly linked with dietary patterns are reviewed. 
Our understanding of foods and macronutrients in relationship to CVD is broadly clear; however 
major gaps exist both in dietary pattern research and ways to change diets and food systems. 
Based on the current evidence, the traditional Mediterranean-type diet, including plant foods/
emphasizing plant protein sources, provides a well-tested healthy dietary pattern to reduce CVD.
Keywords
diet; food consumption; low and middle income countries; food system; cardiovascular disease; 
climate change
I. INTRODUCTION
There is much controversy surrounding the optimal diet for cardiovascular (CV) health. Data 
relating diet to cardiovascular diseases (CVDs) has predominantly been generated from 
high-income countries (HIC), but over 80% of CVD deaths occur in low- and middle-
income countries (LMIC). Relatively sparse data on diet and CVD exist from these countries 
though new data sources are rapidly emerging (1,2). Non-communicable diseases (NCDs) 
are forecasted to increase substantially in LMIC because of lifestyle transitions associated 
with increasing urbanization, economic development and globalization. The Global Burden 
of Disease study cites diet as a major factor behind the rise in hypertension, diabetes, 
obesity, and other CVD components (3). There are an estimated over 500 million obese (4,5) 
and close to 2 billion overweight or obese individuals worldwide (6). Furthermore, 
unhealthy dietary patterns have negative environmental impacts, notably on climate change.
Poor quality diets are high in refined grains and added sugars, salt, unhealthy fats and 
animal-source foods; and low in whole grains, fruits, vegetables, legumes, fish and nuts. 
They are often high in processed food products – typically packaged and often ready to 
consume – and light on whole foods and freshly-prepared dishes. These unhealthy diets are 
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facilitated by modern food environments, a problem that is likely to become more 
widespread as food environments in LMIC shift to resemble those of HIC (5,7,8).
In this paper, we summarize the evidence relating food to CVD, and the powerful forces that 
underpin the creation of modern food environments -- what we call the global food system -- 
to emphasize the importance of identifying systemic solutions to diet-related health 
outcomes. We do this in the context of increasing global attention to the importance of 
improving food systems by the international development and nutrition community (9–11). 
While the “food system” may feel remote to a clinician sitting in an office seeing a patient, 
its impacts on the individuals they are trying to treat are very real. The paper is based on a 
World Heart Federation international workshop to review the state of knowledge on this 
topic. This review of diet, dietary patterns and CVD is not based on new systematic reviews 
or meta-analyses but represents a careful review of many published meta-analyses, seminal 
primary studies, and recent research by the scholars who participated in the Consensus 
conference.
The paper presents: 1) an overview of the development of the modern, globalized food 
system and its implications for the food supply; 2) a consensus on the evidence relating 
various macronutrients and foods to CVD and its related comorbidities, and 3) an outline of 
how changes to the global food system can address current diet-related public health 
problems, and simultaneously have beneficial impacts on climate change.
II. THE CHANGING FOOD SYSTEM AND FOOD SUPPLY AND 
IMPLICATIONS FOR DIETS AND THE ENVIRONMENT
The development of the modern, globalized food system
Food systems were once dominated by local production for local markets, with relatively 
little processing before foods reached the household (see Supplementary Box 1) (12). In 
contrast, the modern food system is characterized by a global web of interactions between 
multiple actors from farm to fork, geared towards maximizing efficiency to reduce costs and 
increase production (Figure 1). The major actors who control this system have changed 
dramatically in HIC and LMIC, as described below (13).
The shift to a global food system started in the US and other high income industrialized 
countries, and was driven initially by government investment and intervention in markets, 
infrastructure and research intended to raise farm-sector productivity. Building on actions 
taken in the late 19th century (14), policies on agricultural research and supporting on-farm 
production introduced in the 1930–60 period in the US (14) and Europe focused on few 
major crops, particularly grains (e.g., wheat, corn, rice), oilseeds (e.g., soybeans), livestock 
(e.g., pigs, poultry, and cattle) and critical cash crops, especially sugar cane and other 
sources of sugar (15–18). State intervention in most LMICs, took a different form, such as 
policies to subsidize food, taxes on agricultural producers; and systems to control the supply 
and marketing of key commodities (19–22). The 1960s also saw the start of significant 
agricultural transformation in LMIC, with the “Green Revolution” in which focused on 
increasing productivity of corn, rice and wheat.
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These investments and changes in production systems were designed to make calories from 
staples (e.g., wheat, corn, rice) cheaply available, in order to simultaneously address hunger 
in LMIC and national food insecurity in HICs (23). In addition to vastly increasing the 
calorie supply, the ensuing productivity boom also provided the basis of cheap feed for 
livestock and cheap inputs for processed foods, in turn creating incentives for the growth of 
manufacturers of processed foods (24). This coincided with huge technological innovations 
in food processing, (24–28), the rise of to mass marketing to persuade consumers to eat 
more, supermarket retailing and fast food (29) (30), As a result of these changes, the 
transformation of raw commodities into food and the distribution of consumable food items 
beyond the farm gate has become far more important (31). Today integration and control of 
our farm to fork food supply by major agribusinesses, food manufacturers, retailers, food 
service companies is more the rule that the exception (13). Meanwhile, production of less 
processed foods such as coarse grains (e.g., millet, sorghum), roots, tubers, and legumes has 
declined (32,33) while animal source food production grown dramatically (34).
Figure 2 sets out the stages of change involved in leading to this modern food system. This 
model has spread unevenly to most LMIC (35–37). Many countries retain various forms of 
state intervention in agriculture and food systems (18,38–41), but policies to liberalize trade 
and private sector investment have revolutionized the entire sector in many regions (13,42). 
Retailing has been transformed in LMIC through the growth of supermarkets (18,38–41). 
While this process originated with companies in industrialized countries looking for growth 
in foreign markets, companies based in LMICs are now also investing back into HICs.
Dietary impacts
The way people eat has changed greatly across the globe; moreover the pace of change in 
LMIC’s is quickening. Snacking and snack foods have grown in frequency and number (43–
48); eating frequency has increased; away-from-home-eating in restaurants, in fast food 
outlets, and from take-out meals is increasing dramatically in LMIC; both at home and 
away-from-home-eating increasingly involve fried and processed food (47,49); and the 
overall proportion of highly processed food in diets has grown (50,51).
These changes in the global food system coupled with these food behavior shifts have 
enabled some critical changes to the global food supply, all with dietary implications. First 
is the shift to refined carbohydrates – refined grains and added sugars. Rapidly increasing 
production of starchy staples combined with processing technologies mean that refined flour 
is increasingly dominant in diets. White bread, for example, once rarely consumed in Latin 
America, became widespread after the introduction of high-yield wheat varieties. In Asia, 
white rice became dominant as a staple over legumes and coarse grains, with a more recent 
trend being rapidly rising consumption of instant noodles as a staple (52,53). Since 1964, 
average total carbohydrate intake in the US has increased from about 375 g/d to 500 g/d 
(from 2 to 6 kg/year of ready-to-eat cereals), but the percent of carbohydrate that is fiber has 
not substantially changed over this time, reflecting increased refined carbohydrates and 
sugar sweetened beverages (SSBs) is high in HIC (54). In the 1985 to 2005 period extensive 
added sugar intake occurred across HIC (55) but more recently large increases have 
occurred in LMIC, particularly in consumption of sugar-sweetened beverages and processed 
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foods (56–59). Today in the US packaged and processed food supply over 75% of foods 
have some form of added sugar (60). With urbanization there is some evidence to show that 
refined carbohydrate consumption is increasing, whereas consumption of traditional grains 
(i.e. millet, maize) is decreasing in LMIC (61,62).
A second key change has been the increasing intake of vegetable oils, including processed 
vegetable oils, and a decline in consumption of animal fats (2,63). This was initially driven 
by rising production of soybeans in the US, later in Argentina and Brazil, and then palm oil 
in East Asia. Oilseeds are now among the most widely traded crops, and are also processed 
to create margarines and vegetable shortenings and into partially hydrogenated fats and 
bleached deodorized oils for use in processed foods, (see also Supplementary Box 2). 
Between 1958 and 1996, a major global shift occurred in the amount and types of available 
fats, with soybean, palm, and rapeseed/canola oils replacing butter, tallow, and lard. In 
1958–1962, soybean, palm, and rapeseed/canola oils represented 20% of the 29 million 
metric tons of fat produced globally/year, while butter, lard, and tallow represented 37%. By 
1996–2001, these oils accounted for 52% of the 103 million metric tons of fat produced 
globally/year, while butter, lard, and tallow contributed 20% (64). This has implications for 
consumption of fatty acids. Palm oil (deodorized) has become an increasing source of 
saturated fatty acids; and partially hydrogenated fats are the main source of trans-fatty acids 
Between 1990 and 2010, global saturated fat, dietary cholesterol, and trans-fat intakes 
remained stable (trans-fats going down in HIC and up in LMIC), while n-6, seafood n-3, 
and plant n-3 fat intakes each increased (65). Vegetable oil consumption remains two times 
higher in HIC than in LMIC. However, trans-fat consumption is very high in many LMIC 
while decreasing markedly in HIC. In India, for example, vanaspati, a vegetable ghee used 
in bakery products, fried snacks and foods sold by street vendors is a leading source of 
trans-fats, as is bakery shortening. In 75 countries representing 61.8% of the world’s adult 
population, global saturated fat consumption was ≈9% of energy; though considerable 
variation existed across countries (range: 2 to 28%). Country-specific omega 6 consumption 
ranged from ≈1 to 13% (global mean: 6%) of energy; trans-fat consumption ranged from 
≈0.2 to 6.5% (global mean: 1%) of energy; dietary cholesterol consumption ranged from 
≈97 to 440 mg (global mean: 228 mg) per day; seafood n-3 ranged from ≈35 to 3,886 mg 
(global mean: 163 mg) per day; and plant n-3 ranged from <≈100 to 5,542 mg (global 
mean: 1,371 mg) per day (65).
A third key change has been the increasing global consumption of meat, which has been 
made economically feasible by subsidized production of crops for animal feed – most 
importantly corn and soybeans (soybean oil is a byproduct of soymeal production for 
animals) (66–69). At very low levels of intake animal food consumption may not induce 
harm, providing high quality protein and iron, whereas excess animal food intake in HIC 
may be linked to adverse health outcomes, particularly from processed meats (70). Meat 
consumption has increased considerably worldwide, and there is substantially greater 
production of meat in HIC than in LMIC (71). North and South America, Europe, and 
Australia/New Zealand have the highest meat intake, whereas Asia and Africa have the 
lowest (72,73). Processed meats (which refers to post-butchering modifications of foods 
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such as curing, smoking, or addition of sodium nitrate), account for a modest proportion of 
all meat consumed in HIC (unpublished data from the PURE study) (71).
Dietary consumption patterns of other protein sources have been mixed. Between 1973 
and1997, dairy consumption per capita (kg) increased in LMIC by ~48% and is projected to 
almost double (93% increase) by 2020. On average, fish consumption is 2 to 3 times higher 
in HIC than LMIC (74), although with marked heterogeneity within income categories. 
China has the highest per capita consumption of fish in the world, followed by Oceania, 
North America, and Europe (74). Globally, although there has been little or no increase in 
sea fish consumption per capita since the 1960s, catches per year have risen exponentially 
(75) and freshwater fish intake has intake has increased during this time (71). Eggs are 
similarly consumed in higher quantities (2–6 times) in HIC relative to LMIC, with a 14% 
decline in consumption in HIC observed between 1980–2000, and no change was observed 
in LMIC (76). The consumption of legumes declined in the US from 1960 and into the 
1980’s, with reduced consumption patterns observed globally (8). Relatively, HIC such as 
Canada, US, and Western Europe, tend to consume the lowest quantities of legumes per 
capita in the world, whereas LMIC within Africa and India consume the greatest quantities 
of legumes, along with certain South American countries where beef is uncommon, such as 
Colombia and Peru (77–79). Globally, pulse consumption has decreased since 1961, from 
≈9.5 kg/person/year in 1961 to 6.5 kg/person/year in 2006. In LMIC countries pulses 
contributed ≈4% of energy to the diets, and just 1% of energy to diets of HIC (80). Total 
production of tree nuts in 2012 was 3.5 million metric tons, a 5.5% increase from 2011. 
World consumption of tree nuts in 2011 exceeded 3 million metric tons (81).
A fourth key change is the marked growth of purchases of all packaged foods and beverages 
(all categories of processing). This process is accelerating across all LMIC markets 
(13,82,83). For example, 58% of calories consumed by Mexicans come from packaged 
foods and beverages, which is similar throughout the Americas (83) and even with the US 
(66%) (65,84). The proportion for China is 28.5% and rising rapidly (36,82,83). The 
component that is “ultra-processed” – ready to eat, of snack, foods – varies depending on the 
method of measurement but is increasing wherever it is studied at all income levels 
(50,85,86). The shift to ultra-processed foods has not just affected the food available for 
consumption but also the way food is consumed (87). The way people eat has changed 
greatly across the globe and the pace of change is quickening. Snacking and snack foods 
have grown in frequency and number (43–48); eating frequency has increased; away-from-
home-eating in restaurants, in fast food outlets, and from take-out meals is increasing 
dramatically in LMIC; both at home and away-from-home-eating increasingly involve fried 
and processed food (47); and the overall proportion of highly processed food in diets has 
grown (50,51).
A fifth trend noted above in relation to the added sugar change is the shift in the way LMIC 
are experiencing a marked increase in added sugar in beverages. In the 1985 to 2005 period 
extensive added sugar intake occurred across HIC (55) but more recently large increases 
have occurred in LMIC’s, particularly in consumption of sugar-sweetened beverages and 
ultra-processed foods (56–59). Today in the US packaged and processed food supply over 
75% of foods have some form of added sugar (60).
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In addition, fruit and vegetable intake has remained inadequate. Fruit and vegetable 
consumption is substantially higher in HIC compared to LMIC (88). Analysis of 52 LMIC 
countries taking part in the World Health Survey (2002–2003) (89) found that low fruit and 
vegetable consumption (i.e., less than 5 fruits and vegetables per day) prevalence ranged 
from 36.6% (Ghana) to 99.2% (Pakistan) for men and from 38.0% (Ghana) to 99.3% 
(Pakistan) for women. Overall, 77.6% of men and 78.4% of women consumed less than the 
minimum recommended five daily servings of fruits and vegetables. In the US, 32.6% of 
adults consumed fruit two or more times per day and 27.2% ate vegetables three or more 
times per day (90). In 2012, 40.6% of Canadians aged 12 and older, reported consuming 
fruit and vegetables five or more times per day (91).
While all of these changes across LMIC display great heterogeneity (92), the global food 
system has clearly reached all corners of the LMIC urban and rural sector and major shifts in 
diets appear to be accelerating.
Implications for environmental impacts
The modern food system is a major force in a range of serious environmental problems, 
including climate change [as a leading source of greenhouse gas (GHG) emissions, 
including carbon dioxide, methane, and nitrous oxide], the loss of biodiversity, the strain on 
freshwater resources, and the release of persistent toxins, excess nitrates and phosphates 
(from fertilizer and concentrated livestock operations, causing widespread problems of 
eutrophication), and animal pharmaceutical residues into waterways (12,93–95).
The major causes are beef and other large animals for GHG and the metabolic losses 
associated with shifting the product of nearly one third of the world’s arable land to 
concentrated animals, which effectively magnifies the resource budgets and pollution loads 
of industrial monocultures (34). The expansion of low-input agriculture and extensive 
ranching are also major factors in deforestation, which bear heavily on both climate change 
(as carbon is released from vegetation and soils and sequestration capacity diminishes) and 
biodiversity loss.
In addition to being a major force in many environmental problems, world agriculture is also 
extremely vulnerable to climate change, biodiversity loss, declining freshwater availability, 
and the inevitable limits of non-renewable resources (e.g., fossil energy, high grade 
phosphorous) although vulnerability is highly uneven on a world scale (96). Many of the 
world’s poorest regions are poised to be most adversely affected by rising average 
temperatures, aridity, and water stress, as well as through increasingly severe extreme 
weather events like drought or flooding; in fact some feel this is already occurring (97–99).
It is also noteworthy that the FAO estimates that one-third of all food produced for human 
consumption globally is wasted before it is consumed, which has both social and 
environmental costs that have been precisely measured in the US (100–102). Waste affects 
the entire food system from production to post harvest (including inside the home) (102). 
Hall’s estimate to home food waste of about 1400 kcal/capita for the US adds up to 25–45% 
waste of total food for some HIC (101).
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III. MACRONUTRIENTS, FOODS, AND CVD RISK FACTORS
Carbohydrates
Refined Carbohydrates
a) CVD Risk Factors: Ecological evidence from the US demonstrates an association of 
refined carbohydrate (as corn syrup) with type 2 diabetes (T2DM) and obesity (54). Robust 
data from systematic reviews and high-quality RCTs support a harmful effect of highly-
refined, high-glycemic-load carbohydrates. A meta-analysis of observational studies 
indicated that high–glycemic index (GI) foods are associated with T2DM (103). Proof-of-
concept studies have used alpha-glucosidase inhibitors, such as acarbose, to lower the 
glycemic index of the foods consumed; for example, in the STOP-NIDDM trial, acarbose 
reduced progression to T2DM by 25% compared with placebo (104). T2DM risk in 
individuals with the highest glycemic load (GL) and lowest cereal fiber is 2.5-fold that of 
those with the lowest GL and highest cereal fiber diet (105). A large Danish prospective 
cohort study of the impact of replacing saturated fats with high-GI carbohydrates found that 
when high-GI carbohydrates replace saturated fat, myocardial infarction (MI) risk increases 
33% (106). A meta-analysis of 10 prospective cohort studies (n=296,849) (107) found 
increased GL associated with a 27% increased coronary heart disease (CHD) and MI risk 
(108). In controlled-feeding studies, replacing saturated fat with carbohydrates lowers low-
density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol and increases 
triglycerides (109). Dietary interventions which raise HDL-C may not necessarily translate 
into CVD risk reduction, as serum HDL-c has recently been called into question regarding 
its role in the causal pathway of CVD (110). However, in a 5-week controlled-feeding trial 
of 163 generally healthy but overweight adults, low compared with high-glycemic index 
diets did not improve insulin sensitivity, lipid levels, or systolic blood pressure in the 
context of a healthy, DASH-like dietary pattern, and a low compared with high-glycemic 
index diet increased LDL-C when the carbohydrate content of the diet was high (109). This 
study suggests that the adverse effect on CHD risk may not be mediated by short term 
effects on classical risk factors, but that postprandial hyperglycemia and hyperinsulinemia or 
hyperlipidemia may play a mediating role; further work is needed to clarify the effect of the 
glycemic index on LDL-C and related lipid risk factors.
b) LMIC: Highly refined carbohydrates include polished white rice, cornstarch, and white 
wheat flour with reduced fiber content. Carbohydrate refinement is common in HICs and 
increasing in LMIC (111,112). Traditional diets in LMIC, once rich in whole grains and 
dietary fiber, now include highly refined carbohydrates, such as polished white rice and 
refined flours. In East Asian countries, white rice consumption is associated with a 55% 
higher T2DM risk (111,112). In the cross-sectional CURES 57 study, higher refined grain 
intake was associated with higher waist circumference, systolic and diastolic blood pressure 
(SBP and DBP), fasting glucose, triglycerides, and insulin resistance and lower HDL-C 
levels (61). Replacing white with brown rice (50 grams/day) reduced T2DM risk by 16% 
(113), and substituting beans for white rice reduced the odds of metabolic syndrome by 35% 
(108). However, a 16-week randomized trial of replacing white with brown rice in middle-
aged Chinese men and women with or at high risk for T2DM only improved HDL-C and 
reduced DBP in the brown rice group. Data from the international Prospective Urban and 
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Rural Epidemiological Study (PURE; 138,926 individuals in 628 communities 17 countries) 
suggest a need to consider the context and availability of specific foods before making food 
choice recommendations (114). Increasing whole grain and cereal fiber consumption, while 
decreasing total and high-GI carbohydrate, are helpful strategies to prevent T2DM and CVD 
in the general population (115). Furthermore, low-glycemic index diets improve glycemic 
control and serum lipids in RCTs of participants with T2DM with major implications for 
CHD risk reduction in this vulnerable segment of the population whose numbers are 
increasing rapidly globally (116–119).
Sugar-Sweetened Beverages
a) SSB and CV Risk Factors: Sugar-sweetened beverage (SSB) consumption accounts for 
up to 50% of added sugar in the American diet (120,121). The epidemiological relationships 
between SSB consumption, overweight, obesity, hypertension, and T2DM are strong (122). 
In a meta-analysis of prospective studies of SSB and hypertension, CHD, and stroke, the RR 
for a 1-serving increase in SSB/d was 1.17 (95 % CI 1.10, 1.24) for CHD and 1.08 (95% CI: 
1.04 to 1.12) for incident hypertension, but no clear effect was seen for total stroke (RR 
1.06, 95 % CI 0.97, 1.15) (123). A meta-analysis of seven cohort studies and five 
randomized controlled trials (RCTs) found SSB’s increased weight by 0.12 kg/serving/year 
(95% confidence interval [CI]: 0.10–0.14) in adults (124). A World Health Organization 
(WHO) systematic review reported similar positive associations (125). In a pooled analysis 
of Nurses’ Health (NHS) and Health Professionals Follow-up Study (HPFS) data, a one SSB 
serving/day increment is associated with a 1-kg weight gain over a four-year period (126), 
possibly due to incomplete compensation for this energy at other meals. After adjusting for 
important potential confounders, including body mass index (BMI), ≥ 1/d versus < 1 
SSB/mo increased T2DM by 39% (127). A meta-analysis of 310,819 participants and 
15,043 cases of T2DM reported a 26% increased T2DM risk among those consuming 1–2 
SSB servings/day compared to non-consumers (128). A meta-analysis of 4 cohort studies 
reported a linear association between SSB and hypertension risk [RR: 1.08 (95 % CI: 1.04, 
1.12) per serving/d] (129). The Framingham Offspring Study reported a 22% higher 
incidence of hypertension among those consuming ≥ 1 SSB serving/day compared with non-
consumers (130). A potential explanation of the SSB-T2DM association is the high content 
of rapidly-absorbed sugar from corn syrup, which increases blood glucose and insulin and 
de novo lipogenesis –which may contribute to pancreatic beta cell dysfunction and 
eventually T2DM (131). In the National Health and Nutrition Examination Survey III 
(NHANES III), with 831 CVD deaths during 163,039 person-years of follow-up, 
consumption of ≥ 7 SSB servings/week was associated with a 29% increased CVD mortality 
risk compared with < 1 serving/week (120), with no increased risk up to 6 drinks/week. Few 
studies have investigated the association between SSBs and CVD events. Those that have 
report increased CHD and stroke risk with SSB consumption. A 2015 meta-analysis reported 
a relative risk for incident CHD of 1.17 (95 % CI: 1.10, 1.24) per serving/d increase in SSB 
consumption (129). Both the HPFS and the NHS find a ≈20% increased CHD risk in the 
highest category of SSB consumption compared with the lowest category (132,133); and, 
after adjusting for dietary and non-dietary cardiovascular risk factors, a 16% increased 
stroke risk (134). Similarly, two Swedish prospective cohort studies in women and men 
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reported a relative risk (RR) of 1.19 (95% CI: 1.04 and 1.36) for stroke among those 
consuming ≥ 2 SSB servings/day (135).
b) LMIC: Facing health concerns, the beverage industry is shifting from full-calorie 
carbonated soft drinks (CSDs) to lower-calorie CSDs, coffees, and teas. According to the 
NHANES, between 1999 and 2006 the average US full-calorie CSD intake decreased, while 
intake of diet CSDs, low-calorie fruit drinks, and other sweetened beverages increased 
(122). These products will gradually enter the markets in China, Brazil, and other LMICs. 
However, there are practically no data on the effects of SSBs on health outcomes from 
LMIC (136,137).
Fats and Oils
a) CVD Risk Factors: Vegetable oils that are primarily comprised of mono- (e.g., olive oil) 
and polyunsaturated fatty acids appear to reduce CHD risk, and sources of the n-3 
polyunsaturated fat alpha-linolenic acid (ALA), such as rapeseed or canola oil, are 
cardioprotective. Replacing saturated fat with monounsaturated or polyunsaturated fat 
reduces low-density lipoprotein cholesterol (LDL-C) and preserves HDL-C (109). Further, 
canola oil, as part of a low-glycemic index diet, improves glycemic control and blood lipids 
in type 2 diabetes (138). Trans-fatty acids increase CHD risk compared with other 
macronutrients, with strong evidence of adverse effects of small amounts of trans-fats on 
lipids (109,139) and CVD risk (140,141).
Though total fat (142), and specifically saturated fats, have generally been considered to be 
deleterious to insulin sensitivity (143), in large cohort studies, saturated fat is not associated 
with development of T2DM, after adjustment for BMI, total dietary fiber, or magnesium 
intake (144–149). Macronutrient exchange generally does not influence markers of glucose 
homeostasis, though in two relatively large trials, replacing SFA with either MUFA or 
carbohydrate improved indices of glucose homeostasis (150,151). Associations have been 
seen between major food sources of saturated fat, such as red and processed meat, and 
development of T2DM (152,153), though dairy products, notably fermented dairy, may be 
protective (154,155).
b) CVD: Saturated fats have not been consistently associated with CVD in meta-analyses of 
cohort studies (odds ratio [OR]: 1.07; 95% CI: 0.96–1.19) of higher compared with lower 
intakes (156). However, in most of these studies the association of high saturated fat intake 
largely represents replacing highly refined carbohydrates. Replacing saturated fat with 
highly refined carbohydrate is not associated with lower CHD risk, whereas replacing 
saturated fat with polyunsaturated fat reduces CHD risk (157,158). This benefit of 
polyunsaturated fat includes the primary n-6 polyunsaturated fatty acid, linoleic acid 
(158,159). Replacing saturated fat with high-GI carbohydrate increases MI risk by 33%, 
whereas replacing with low- and medium-GI carbohydrates appears neutral (106). Emerging 
evidence suggests that the effect of a saturated fat on CHD may depend on the type of fatty 
acid and the specific food source (i.e., dairy vs. meat) (160,161). Consumption of non-
hydrogenated vegetable oils appears to be superior to consumption of animal fats (162). 
Consumption of plant oils in a Mediterranean diet reduced CVD in two RCTs. The Lyon 
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Diet Heart Study found regular consumption of ALA (canola oil) significantly reduced 
cardiac deaths and nonfatal CHD (163), while the PREDIMED RCT found that a 
Mediterranean diet (50 grams/d extra virgin olive oil) reduced CVD events by 30% in over a 
five-year period (164).
Palm oil is the dominant fat globally and is relatively high in saturated fat. Based on 
controlled-feeding studies examining changes in blood lipids, replacing palm oil with 
unsaturated fatty acids would be expected to lower CHD risk (109), but palm oil would be 
preferred to partially hydrogenated oils high in trans-fatty acids. Few studies have directly 
compared palm oil with other oils for CHD risk. One large case-control study in Costa Rica 
found that soybean oil consumption was associated with lower acute MI risk compared to 
palm oil consumption (165).
Summary of Fats and Oils: compared to saturated fat, vegetable oils rich in 
polyunsaturated fats reduce the TC:HDL-C ratio and CHD incidence; inclusion of n-3 fatty 
acids (ALA) with the vegetable oils is important for CHD prevention. The effect of 
replacing saturated fat with carbohydrate on CHD risk appears to depend on the quality of 
the carbohydrate. Prospective studies consistently indicate adverse effects of trans-fats on 
CHD. Effects of monounsaturated fat from plant sources require further study; extra virgin 
olive oil appears to reduce CVD.
Protein sources
Meats
a) Nutrients and CVD Risk Factors: Meat is rich in protein, iron, zinc, and B-vitamins, 
but can also contain significant amounts of cholesterol and saturated fatty acids, which raise 
LDL-C and lower triglyceride (157). A high red meat intake (rich in heme iron), increases 
endogenous formation of N-nitroso compounds in the gastrointestinal tract that are 
associated with increased epithelial proliferation, oxidative stress, and iron-induced hypoxia 
signaling (166–168).
In a meta-analysis of 17 cohort studies (16 from Western countries), consumption of red and 
processed meat increased T2DM and CHD risk; but few included studies examined 
unprocessed red meat (169). Intake of red or processed meat was not associated with stroke, 
but only three studies evaluated these relationships (169). In more recent analyses, red 
meats, particularly processed red meats, were associated with increased CVD, CHD, stroke, 
and cancer mortality, while poultry was not (170–172). Potential mechanisms linking 
unprocessed red meat with CVD include saturated fat, cholesterol, iron, 
phosphatidylcholine, and carnitine; and cooking methods (e.g., barbecuing), that increase 
heterocyclic amine content and N-nitroso compounds, also implicated in colorectal cancer 
(167). The evidence suggests that processed meat consumption increases CHD risk, while 
unprocessed meat consumption has a small or no association with CHD, mainly when 
compared to refined starch and sugar. Both unprocessed and processed red meats are 
associated with greater CVD risk compared to poultry, fish, or vegetable protein sources. 
Both types of meat are associated with higher T2DM risk, although gram-for-gram the effect 
size is notably larger for processed meats.
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b) LMIC: Data relating meat consumption to CVD risk in LMICs is limited. A recent 
pooled analysis of data from 296,721 individuals from Asian countries (i.e., Bangladesh, 
mainland China, Japan, Korea, and Taiwan) found no association between red meat and 
poultry consumption and CVD, cancer mortality, or all-cause mortality (173). Red meat 
intake is generally much lower in these areas than in HICs however, and current 
consumption does not likely reflect long-term patterns.
Dairy
a) CVD Risk Factors: The consumption of dairy products has been associated with weight 
loss in small studies (174), but the overall literature does not confirm an important effect on 
body weight. However, increased low-fat dairy consumption is associated with lower LDL-
C, triglycerides, plasma insulin, insulin resistance, waist circumference, BMI, possibly 
blood pressure (BP); and reduced diabetes risk (174–182). In a large meta-analysis of cohort 
studies (13,000 incident cases), and the EPIC InterAct case-cohort study (12,000 incident 
cases), fermented dairy (i.e., yogurt, cheese, and thick fermented milk), but not total dairy, 
was inversely associated with T2DM (155,183). In a meta-analysis of prospective cohort 
studies, milk consumption was inversely associated with total CVD in a small subset of 
studies with few cases, but using a larger body of data with more specific endpoints, milk 
was not associated with CHD or stroke (173). In a prospective cohort study of 53,387 
Japanese men and women, higher dairy calcium (173 mg/d vs. none) reduced risk for 
hemorrhagic stroke, ischemic stroke, and stroke mortality by ≈50% over a 10-year follow-
up (184). Collectively, these studies do not suggest a strong or consistent relationship 
between consumption of dairy products and T2DM and CVD risk.
b) LMIC: Data on dairy consumption and CVD in LMICs are limited. In a prospective 
cohort of 2,091 middle-aged Chinese men and women monitored for six years, individuals 
who reported consuming > 1 dairy serving/day were 35% less likely to develop T2DM (RR: 
0.65; 95% CI: 0.49 and 0.85) than nonconsumers (185).
Egg
a) CVD Risk Factors: Eggs are a relatively inexpensive and low-calorie source of protein, 
folate, and B vitamins (186). Eggs are also a source of dietary cholesterol (a medium egg 
contains ~225 milligrams of cholesterol) (187). A meta-analysis showed that eggs increase 
TC, HDL-C, and TC:HDL-C,(188) but five RCTs subsequently reported that egg 
consumption did not significantly alter these parameters (189–191) or endothelial function 
(192,193). No RCT has tested the effect of egg consumption on CVD events. In a meta-
analysis (194) of 16 prospective cohort studies (90,735 participants) (191), egg consumption 
was not associated with overall CVD or CHD, stroke, or CHD or stroke mortality; but was 
associated with T2DM. Overall, consumption of eggs in moderation (one egg/day) is likely 
neutral for CVD. However, relative to other protein-rich foods that lower LDL cholesterol, 
such as whole grains and nuts, eggs would likely increase CVD risk.
b) LMIC: Unpublished data from three large international studies, PURE, ONTARGET, 
and INTERHEART, with collectively 200,000 individuals and 22,000 CVD events from 
regions including China, India, and Africa, show that moderate egg consumption appears to 
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be neutral or protective against CVD. However, significant variations exist across regions, 
with a benefit of daily egg consumption in China but possible harm in South Asia.
Fish
a) CVD Risk Factors: Fish are a source of protein, vitamin D, multiple B vitamins, 
essential amino acids, and trace elements; and the long-chain omega-3 (n-3) fatty acids 
docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) (195,196), though amounts 
vary over tenfold across seafood species. Fatty fish, such as salmon, sardines, trout, white 
tuna, anchovies, and herring, have the highest concentrations. In clinical trials and meta-
analyses of these trials the long-chain omega-3 polyunsaturated fatty acids in fish reduced 
multiple CVD risk factors, including vascular resistance, BP, inflammation, serum lipids, 
and endothelial function (197).
Some prospective cohort studies find an inverse association between fish intake and CVD 
mortality, whereas others do not (198). Available evidence suggests cardiovascular benefits 
with fish consumption in secondary prevention, but the evidence is inconsistent regarding 
primary prevention. Possible explanations include differences in the amounts and types of 
fish consumed, cooking methods, and background fish consumption. Fifteen of the 16 cohort 
studies [exception (199)] were conducted in North America and European countries, where 
deep-frying fish is common. The Diet and Reinfarction Trials (DART-1), a secondary 
prevention trial and DART-2, in men with stable angina, are the only randomized trial of 
fish intake and CVD outcomes. They arrive at opposite conclusions. In DART-1, fish 
lowered all-cause mortality and trended towards reducing CVD events after 2 y (194). In 
DART-2 oily fish did not affect all-cause mortality or CVD events after 3–9y, and increased 
sudden cardiac death, largely confined to the subgroup given fish oil capsules (200). 
Differential behavioral change or CVD stage may explain the discrepancy (201). Follow-up 
of DART-1 at 5y also showed increased rates of CVD in the fish/fish oil group that did not 
persist through the 10y assessment (202). We know of no primary prevention trial on fish 
intake and CVD outcomes, but a meta-analysis of fish oil supplement RCTs is neutral (203).
b) Low-income Countries and HICs: Most of the data indicating that fish is protective 
comes from studies in HICs (204–208). (204,205). Unpublished data from three large 
international studies (PURE, ONTARGET, and INTERHEART) reflect considerable 
heterogeneity in the association between fish intake and CVD outcomes. In the PURE study 
fish intake was inversely associated with CVD outcomes in South America, China, North 
America, and Europe (RR: 0.76–0.84) but positively associated in South Asia (RR: 1.97). 
However, no associations between fish consumption and CVD outcomes were observed in a 
high-risk secondary population in ONTARGET. INTERHEART found fish intake beneficial 
in North America and Europe (RR: 0.73; 95% CI: 0.62–0.87) but harmful in the Middle East 
(RR: 1.59; 95% CI: 1.32–1.93). More work is needed in China and India to understand the 
effects of regional types and preparation methods of fish a.
Nuts
a) CVD Risk Factors: In clinical trials nuts improve serum lipids (209) (210,211). In 
observational studies, nuts lower CHD (196,212,213) and hypertension risk (213); but not 
Anand et al. Page 13













stroke (207, (213). In one meta-analysis of prospective cohorts, nuts were not associated 
with T2DM (214), but in another, they were protective (207). Despite their high energy 
density, nuts do not contribute to weight gain, changes in waist circumference, or obesity 
perhaps owing to their satiating effects and increased fecal energy losses. (215,216). In 
observational studies (133,217–220) and RCTs (164,221–223) a Mediterranean diet 
including nuts lowers CVD risk. However, no RCTs have assessed the effects of nut 
consumption alone on CVD events. Taken together, the published data from observational 
studies and clinical trials support nuts for lowering CVD risk.
b) LMIC: Unpublished data from the PURE cohort indicate that nut consumption is very 
low in LMIC (60% of individuals consume ≤ 1 nut serving/week). No associations between 
nut consumption and CVD outcomes is seen at this low level.
Legumes
a) CVD Risk Factors: In observational studies and RCTs consumption of legumes 
improves CVD risk factors, such as waist circumference, cholesterol, BP, C-reactive protein, 
glucose; and is protective against T2DM (224–231). A meta-analysis of 26 RCTs (1,037 
participants) finds that 130 grams legumes/d (~1 serving) reduced LDL-C by 0.17 mmol/L 
(95% CI: −0.25, −0.09) (228). Legumes also reduce SBP (by 2 mmHg) and lowered mean 
arterial pressure(231) in a meta-analysis of eight RCTs. A legume-rich diet reduced HbA1c 
(−0.3%; 95% CI: −1.4, −0.1%) in an RCT in participants with diabetes (226).
b) CVD: In a meta-analysis of five observational studies, 100 grams of legumes four times/
week is inversely associated with CHD (RR: 0.86; 95% CI: 0.78–0.94) (232). However, that 
study and another meta-analysis of eight prospective cohort studies found no association 
between legumes and diabetes (207) or stroke (232,233). A large prospective study of two 
cohorts of US health professionals found a 45% increased risk of ischemic stroke per daily 
serving of legumes (RR: 1.45; 95% CI: 1.06–2.00) (234). This suggests that while legumes 
are valuable to reduce CHD risk, more research is required to understand their impact on 
total stroke risk.
c) LMIC: In a cohort of Chinese men and women, soy (the primary legume consumed in 
China) was negatively correlated with TC and LDL-C (235). A population-based cross-
sectional study in India found that women consuming legumes once/day were less likely to 
develop T2DM (OR: 0.55; 95% CI: 0.34–0.88; n=99,574). A similar but non-significant 
trend was observed in men (OR: 0.70; 95% CI: 0.39–1.26; n=56,742) (236). In a prospective 
cohort study of middle-aged Shanghai women, a ~50 gram/day increase in legume 
consumption over 4.6 years reduced T2DM risk by 38% (RR: 0.62; 95% CI: 0.51–0.74) 
(237). A prospective cohort study of 64,915 Chinese women aged 40 to 70 (n=62 cases; 
follow-up 2 y) found that individuals consuming ≥ 11.2 grams/day of soy protein were less 
likely to develop CHD (RR: 0.25; 95% CI: 0.10 to 0.63) than those consuming ≤ 4.5 
grams/day (238).
Summary of major protein sources: Reducing red meats, especially processed meats, and 
increasing fish, nuts, legumes, and possibly fermented dairy products are likely beneficial. 
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Sustainability issues discussed in this paper must also be addressed specifically in relation to 
meat, fish, and dairy foods (12,34,239–241).
Fruits and Vegetables
a) CVD Risk Factors: In the Dietary Approaches to Stop Hypertension (DASH) RCT, 
higher intake of fruits and vegetables, either as part of a typical Western diet or the DASH 
eating plan, reduced BP, TC, LDL-C, and HDL-C without affecting triglycerides (242). A 
meta-analysis of three prospective cohorts (3,415 cases) found high adherence to the DASH 
eating reduced T2DM risk by 27% (243). A strong evidence base from observational studies 
indicates that high consumption of vegetables and fruits reduces CHD and stroke (196).
b) CVD in HIC and LMIC: Large global studies and systematic reviews of prospective 
cohorts generally support a protective role of fruits and vegetables against CVD (244–246). 
In the global INTERSTROKE study (3,000 stroke cases and 3,000 controls), compared with 
fewer than 1 serving per day, 1 serving of fruit was protective against stroke (OR: 0.61, 95% 
CI: 0.50 to 0.73), but the benefits were not clear with higher consumption of up to 3 
servings/d of vegetables was not t (OR: 0·91; 95% CI: 0.75 to 1.10) (244). A meta-analysis 
of 20 prospective cohort studies (16,981 stroke events) found that fruit and vegetable 
consumption was associated with decreased stroke risk (RR: 0.79; 95% CI: 0.75–0.84 for 
highest vs. lowest categories), as were fruits (RR: 0.77; 95% CI: 0.71–0.84) and vegetables 
(RR: 0.86; 95% CI: 0.79–0.93) separately (245). In unpublished INTERHEART data a one-
serving/day increase in fruit decreased MI risk by 12% (RR: 0.88; 95% CI: 0.84–0.92); a 
one-serving/day increase in vegetables decreased MI risk by 5% (RR: 0.95; 95% CI: 0.92–
0.97). Large meta-analyses of observational studies support a ≈5–10% reduction in CVD 
mortality per serving per day (246), and a protective association of green leafy vegetables 
with T2DM (RR per 0.2 servings/day: 0.87; 95% CI: 0.81–0.93) (247). The beneficial 
effects of fruits and vegetables appear consistent across regions of the world. A major issue 
has been the lack of success in encouraging increased fruit and vegetable consumption by 
the citizens of western nations (248).
Overall Summary: Increased refined grains, starches, and added sugar (i.e., carbohydrates 
of lower quality) has paralleled the rise in obesity and T2DM. Collectively, the data support 
emphasizing low-GI whole grains, legumes, fruits, and vegetables and minimizing high-GI 
refined grains and foods with added sugars, including SSBs.
Dietary Sodium
Sodium is an essential nutrient required for normal physiological function (249) (250,251). 
Increasing sodium intake well beyond physiological requirements increases BP (241–243) 
and CVD mortality (95–97). In LMIC sodium sources include table salt and salt additives 
and spices; while processed foods are the primary source in HICs. Sodium consumption has 
declined slightly in LMIC as refrigeration has replaced salted-preserved foods. RCTs have 
reported reductions in BP with reduced sodium intake to < 1.5 grams/day. Population- 
recommendations for low sodium intake (252–254) (< 2.0 grams/day) have been achieved in 
short-term feeding clinical trials (254), but not sustained in longer-term clinical trials (> 6 
months) (255) (256,257). No RCTs have determined whether low sodium intake reduces 
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CVD events or deaths compared with moderate intake (249). Meta-analyses of CVD event 
trials did not report a significant reduction in CVD with lower sodium intake, but the 
included trials were underpowered to detect moderate risk reductions (258). Prospective 
cohort studies suggest a J-shaped association between sodium intake and CVD events, 
consistent across methods of sodium estimation (259–265). In a recent Cochrane Review 
(266) of 23 epidemiological studies (n=274,683), the lowest risk of CVD events and deaths 
occurs at an intake between 2.7 and 5.0 grams/day. PURE study findings (263) are 
consistent with this evidence, with both high (> 6 grams/day) and low (< 3 grams/day) 
sodium excretion associated with higher mortality and CVD events compared to average 
(4.00–5.99 grams/day) sodium excretion despite a positive association between sodium 
excretion and BP (251,263). The increased risk of CVD events with higher sodium intake (> 
5 grams/day) was most prominent in those with hypertension (263). However, 
methodological issues make studies of sodium intake particularly challenging (267). Large 
RCTs are needed for definitive evidence on optimal sodium intake for preventing CVD 
events (249,268–270).
Alcohol
a) Consumption patterns: Greater amounts of alcohol are consumed per capita by adults in 
HIC (9.6 litres/y) than in LMIC (4.1 litres/y), or LIC (3.1 litres/y), although this may be an 
underestimate in LMIC and LIC due to the use of homemade or unsafe alcohol products 
(e.g., industrial or medical) (271). In the PURE study, 31% of participants identified as 
current drinkers, with considerable variation across income regions (13–80%). In all regions, 
men were more likely to be current drinkers than women (272).
b) CVD Risk Factors: In a meta-analysis of randomized controlled intervention studies of 
2–8 weeks’ duration (273), moderate alcohol consumption (up to one drink or 15 g/d in 
women; or up to 2 drinks or 30 g/d in men) compared with no alcohol: raised HDL-C, Apo-
A1, and adiponectin and reduced LDL-C and fibrinogen. Total cholesterol, triglycerides, and 
lp (a) were not significantly affected. Results stratified by beverage type (wine/beer/spirits) 
were similar to the pooled analyses. The changes in lipid and hemostatic risk factors align 
with lower cardiovascular risk.
c) CVD: The European Prospective Investigation on Cancer and nutrition (EPIC) study 
monitored 380,395 participants for 13 years (4,187 CVD deaths) (274). Female never-
drinkers were at increased risk of CVD death (RR: 1.31; 95% CI: 1.13 to 1.53) compared 
with moderate drinkers (0.1 to 4.9 g/d); but the association was not significant for male 
never-drinkers (RR: 1.20; 95% CI: 0.89 to 1.62). In a dose-response meta-analysis of 24 
prospective cohort studies (275), the association of drinking with CHD was J-shaped: non-
drinkers were at slightly increased risk; in men the greatest protection was at 31 g/d with a 
trend for increased risk beginning at 63 g/d; for women, the greatest protection was at 11 g/d 
with a trend for increased risk beginning at 14 g/d. In a meta-analysis of 27 prospective 
studies of alcohol and stroke, no association was found between light or moderate alcohol 
use and stroke, but heavy alcohol use (>45 g/d) was shown to increase total stroke risk (RR: 
1.20; 95% CI: 1.01 to 1.43), particularly hemorrhagic stroke (RR: 1.29; 95% CI: 0.98 to 
1.71) (275). Patterns of alcohol consumption may be a particularly important determinant of 
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the magnitude of the association—in a meta-analysis of 10 prospective cohort and 4 case-
control studies, irregular “binge” drinking (>60 g of pure alcohol or >=5 drinks per occasion 
at least monthly) increased CHD risk by 45% (RR: 1.45; 95% CI: 1.24 to 1.70) (276). In 
summary, small and inconsistent cardiovascular benefit is seen in moderate drinkers, but a 
strong increase in CVD and stroke risk is seen with regular heavy alcohol consumption and 
binge drinking.
d) LMIC: In HIC/UMIC in the PURE study (272), current drinking was protective against 
MI, but not in LIC/LMIC (p=0·02 for interaction); a similar trend was seen for stroke, but 
the between-region difference was not significant (P=0.15 for interaction). In LIC and 
LMIC, heavy episodic drinking pattern and higher intakes of alcohol were associated with a 
composite outcome of mortality, MI, stroke, cancer, injury, and hospitalization. Current 
drinking was associated with an increased risk of alcohol-related cancers.
Summary of alcohol: The CVD risk benefits of moderate alcohol consumption (up to 5 g/d) 
compared with abstinence are small but consistent within individual study populations. 
Higher levels of consumption increase CVD risk, beginning at 30 g/d in women and 45 g/d 
in men. Therefore, recommendations for moderate alcohol consumption for CVD prevention 
in people who already drink must consider individual preferences, population-specific 
responses, and risk of comorbid conditions, such as addiction and cancers. It not 
recommended that non-drinkers take up drinking.
Dietary Patterns
Dietary pattern analysis assesses overall diet quality and is easier to translate into dietary 
recommendations than recommendations for single foods or nutrients (277). The U.S. 
Dietary Guidelines Advisory Committee modeled 3 dietary patterns--the Healthy-US type 
Pattern, the Healthy Mediterranean style Pattern and the Healthy Vegetarian Pattern--for 
healthfulness and nutritional adequacy. All 3 include components of a dietary pattern 
associated with health benefits (277). The DASH diet emphasizes fruits, vegetables, whole 
grains, low-fat dairy products and discourages sugar-sweetened foods and beverages, red 
meat, and added fats (254). The DASH diet was associated with lower SBP, DBP, and 
cholesterol. However, the DASH trials were not designed to evaluate the impact of this diet 
on CVD clinical events. Further improvements in cardiovascular risk factors were seen 
when part of the carbohydrate in DASH was replaced with either monounsaturated fat or 
protein (278). In prospective cohort studies, a higher adherence to a DASH dietary pattern is 
associated with reduced stroke, as well as all-cause, CVD, and cancer mortality (279,280). 
The Portfolio Diet (281), which includes 30 grams/day of nuts, 20 grams/day of viscous 
fiber (i.e., oats, barley, legumes), 80 grams/day of vegetable protein (soy, beans, chickpeas, 
lentils), and 2 grams/day of plant sterols (plant sterol margarine) from plant foods lowers 
LDL-C by up to 30% within four weeks, similar to statins (281). Reductions of 13–23% are 
maintained when this diet was extended to 12 months (282,283). However, no RCT has 
evaluated the impact of this diet on CVD clinical events. Strong evidence from prospective 
cohort studies and randomized trials shows reduced CHD with the consumption of a higher-
fat Mediterranean diet (196). In the PREDIMED randomized trial a plant-based diet high in 
nuts or extra virgin olive oil, vegetables, fruits, legumes, fish, and poultry but low in red 
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meats, sweets, and whole-fat dairy was superior to the control group assigned to a low-fat 
Western diet in preventing CVD (164). It bears mention that low-fat diets have not been 
particularly effective for long-term CVD risk reduction, partly due to the difficulty 
sustaining such a diet long-term (284,285). Table S1 translates the essence of the 
Mediterranean diet to other regions and cultures, suggesting replacement foods that maintain 
the major food groups in particular regions. Randomized trials of CVD outcomes are needed 
in different regions of the world. Supplementary table 1 provides a Mediterranean Style Diet 
adapted to various regions of the world. Figure 3 provides an overview of all the 
components of the food system and the summary of the dietary changes that need to come 
from food system changes.
IV. HEALTHIER FOOD SYSTEMS
If more people made healthier choices, the food systems would have greater incentives to 
produce healthier them. At the same time, a healthier food supply enables individuals to 
make healthier choices. Developing food systems that underpin healthier dietary patterns 
based on our consensus noted above involves improving the food supply by producing more 
heart-healthy foods and fewer foods associated with CVD. It extends beyond merely 
growing and raising these foods to ensuring they reach people everywhere in a still healthy 
form in a way that is accessible and acceptable, including groups of lower-socioeconomic 
status. Changing food systems thus extends beyond agricultural production to what happens 
between farm and fork (31). This is challenging in the modern global food system given the 
often extensive distance between production and consumption; multiple and complex 
transformations in ingredients and foods between farm and fork; and a multitude of other 
forces discouraging diversity and freshness. Producing more poultry, for example, may be 
seen as a way to enhance the quality of the food supply since it is healthier relative to red 
meat, but much chicken is transformed into fast food and other calorie-rich, ultra-processed, 
heavily-advertised presentations (286). Additional public health impacts of industrial poultry 
production are also well-reported, such as food borne disease (e.g., e coli, salmonella, 
listeria), antimicrobial residues, and avian flu (287). Clearly families and individuals also 
play a major role in selecting the quality of their diet, particularly in HIC and among middle- 
and higher-income LMIC, but our focus herein is on the broader environmental factors 
affecting this system.
There are also huge political, economic and environmental challenges to changing the food 
system, not least the capacity of governments to implement change (288). Yet change is 
possible. It can start with a wider understanding of how the modern food system shapes 
dietary patterns and eating behaviors, as supported by education that makes clear the 
interrelationship between food systems, food environments, diets and adverse public health 
and environmental outcomes, and the potential for better diets to lead to major 
improvements in public health and environmental sustainability. The pace and effectiveness 
of improvements will largely depend on political will, encouraged and reinforced by the 
work of civil society, with health-related professionals having important contributions to 
make and Dietary Guidelines sensitive to these issues playing a major role to play.
Anand et al. Page 18













Identifying food system solutions
The task may be daunting, but there are many ways to move towards healthier food systems. 
There is no one solution but a multitude of both top-down and bottom-up starting points. 
Many changes need not be drastic and costly, and small modifications can improve 
nutritional intakes and overall diet quality (see Box 2 for the trans-fat story).
The first “top down” step is to undertake rigorous analytical work at the global level in order 
to identify the main levers for change for each of the food groups and provide a framework 
more conducive to the success of bottom-up approaches (289). The bottom up approach 
starts with engaging communities in finding their own solutions to food system related 
problems with an emphasis on overall dietary patterns (277,290–292).
Experience indicates actions by the following key actors have potential to improve food 
systems, many of which can simultaneously have health and environmental benefits:
• Governments can review policies in various sectors which influence food systems 
for coherence with dietary objectives and realign policies so they “do no harm” 
(293–296); explore fiscal incentives from farm to fork to realign food and 
agricultural systems; and set a coherent framework of standards and regulations for 
large transnational food companies to disincentivize the production, sale and 
marketing of foods high in refined carbohydrates and low in heart-healthy 
elements, including clear standards for promotional marketing (297,298). 
Continued efforts are needed to develop a systems-oriented, mutually reinforcing 
approach to reduce excessive consumption of SSBs (299).
• Communities can identify community-based solutions to poor food access, such as 
through engaging local/small/family farmers and/or innovative community-oriented 
production and marketing of wholegrains, fruits, vegetables legumes and nuts in 
low income communities, and developing local food policy councils (300).
• Farmers and food producers can leverage the potential of traditional/indigenous 
crops as part of biodiverse food systems, and support urban food production. Low-
input, biodiverse farming systems are more sustainable than high-input 
monocultures and tend to be more productive per land area, making greater use of 
ecological space.
• Agricultural and rural development agencies and programs can, where 
wholegrains, fruits, vegetables, legumes and nuts are in short supply in LMIC, 
invest in transportation, distribution networks, procurement logistics and price 
information systems to remove supply bottlenecks.
• Investors in agriculture and food research and development can shift 
investments and research toward the production, distribution and consumption of 
healthier, more diverse sources of nutrients and agricultural programs; make 
national and international investments in food research aligned with a healthy food 
supply; and invest in pre- and post-harvest systems to reduce food waste and 
focusing on recycling in home food waste (101,301).
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• Food processors and manufacturers of all scales can ensure food processing 
does not strip fiber and positive nutrients from foods; direct research and marketing 
to enhance the desirability of nutritious foods to consumers.
• Educational institutions can improve curricula and build capacity among nutrition 
and public health students and professionals to identify and implement multi-
sectorial, food systems solutions to unhealthy diets.
In addition, middle- and high-income countries have introduced measures to improve food 
environments, summarized at www.wcrf.org/NOURISHING. Actions in key countries, 
mainly introduced in the context of obesity, include (302):
• Taxation of sugar-sweetened beverages (SSB’s) and unessential foods (junk foods 
in general) in Mexico. A number of other LMIC’s are considering these taxes, and 
several European countries have introduced taxes on different food groups.
• Front-of-pack labels (FOP) on packaged food products considered healthy (303) or 
unhealthy (304). Several Latin American countries have regulated FOP labels, 
including Ecuador’s traffic light label (implemented in 2014), and Chile’s warning 
label (being implemented over the next 4 years). Several Asian countries are 
developing a healthier choices option.
• Mandatory School food standards are the most widely implemented action, in 
around 11 middle-income countries and 15 high-income countries. However the 
direction of the mandate must be appropriate.
• Effective marketing controls of unhealthy foods and beverages have not been 
widely implemented. Chile’s new program is the most extensive (implemented over 
the 2015–19 period). Mexico, South Korea, the UK and Ireland present rare 
exceptions, but the regulations have loopholes and do not comprehensively restrict 
marketing. Efforts to restrict marketing in other countries through regulation have 
been met with strong opposition from the food and advertising industries. A critical 
issue is to go beyond marketing focused at children’s TV to all TV viewed during 
key hours or full time and also to consider all other media. A second issue is 
linking marketing controls with the FOP labeling efforts so either only healthy 
foods are marketed or all unhealthy foods are not allowed to be marketed.
• Encouraging food processers to produce vegetable-protein rich foods as meat and 
dairy alternatives with subsidies/tax incentives, etc.
While the evidence base for these policy option is growing, more, and more rigorous, 
evaluation of these actions are needed, Econometric evaluations of the Mexican 10% SSB 
tax and 8% junk food taxes are underway using longitudinal nationally representative 
scanned food purchase data at the household level. A critical need is much more evaluation 
of all these options, including to assessments of how they feedback to effect the food system 
(302,305). Nutrition labels, for example, have been shown to have a clear impact on 
reformulation (303,306).
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This paper has provided a state-of-the-art review of the link between specific macronutrients 
and foods and CVD and summarized how the global food system contributes to dietary 
patterns that greatly increase the risks for the population to experience ill health. While 
many perceive food consumption as an individual choice driven by the desires of consumers 
for tasty food, linked with rising incomes and urbanization, we have shown that the food 
system and all the stakeholders within it should play a major role (307).
Short term controlled-feeding studies with CVD risk factors as outcomes, long term 
prospective cohort studies with CHD, stroke and T2DM as outcomes, and a limited number 
of RCTs with CVD as the outcome collectively show that multiple aspects of diet 
substantially influence CVD risk. However, similar data are needed from LMIC as dietary 
patterns differ in various regions of the world and the context in which foods are accessed 
differs markedly.
Based on the current evidence, the optimal dietary pattern to reduce CVD is one that 
emphasizes whole grains, fruits and vegetables, legumes, nuts, fish, poultry, and moderate 
dairy and heart-healthy vegetable oil intake; this pattern will likely reduce the CVD risk by 
about a third. This healthy dietary pattern needs also to be low in refined grains, added 
sugars, trans-fats, SSBs, and red and processed meats. The traditional Mediterranean-type 
diet provides a well-tested prototype for this healthy dietary pattern. Given that we now 
understand the components of this diet sufficiently, it may be possible to translate this 
pattern to other regions, with appropriate similar food replacements based on food 
availability and preferences (see attached Table S1). Despite significant advances in our 
understanding of optimal dietary patterns to prevent CVD, additional research including 
large cohort studies and RCTs of dietary patterns are needed in different regions of the 
world to address existing knowledge gaps. This includes evaluation of the impact of specific 
fruits and vegetables, types of dairy foods, types and amount of carbohydrate, optimal 
cooking oils, regional specific dietary patterns, and cooking methods. Finally, we 
acknowledge that while this paper is focused on CVD, dietary choices and recommendations 
should also be made with consideration of the environmental implications of food choice 
(i.e., the environmental impact of poultry, livestock/cattle production, and diminishing wild 
fish stocks), and the role of diet in other disease processes. Human health must be linked to 
environmental health—the basis of the new Sustainable Development Goals (241). 
Additionally, modifications to our recommendations may provide improved protection 
against cancer or neurodegenerative or auto-immune diseases.
Policy actions and interventions that improve food supplies and dietary patterns have social, 
cultural and environmental benefits. There are many opportunities to increase access to 
healthy food that are also likely to have significant environmental benefits. Health providers 
throughout the world can lead by advocating for action in the food system, as well as in food 
environments and behavior change communication. So too can other professionals, civil 
society and public interest organizations, influential writers and journalists, and 
organizations of chefs and gastronomes. A synergistic systems approach is essential. The 
challenge to create and sustain what is healthy and change what is unhealthy is compelling 
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because improving the nourishment that goes into our bodies can have wide-ranging benefits 
in improving the health of societies and environments. A second major challenge is to 
identify and implement effective food systems and solutions and evaluate the national and 
local level policy actions underway to improve our diets.
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